Literature DB >> 8634010

Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol.

J L Abelson1, G C Curtis.   

Abstract

BACKGROUND: Oversecretion of corticotropin-releasing hormone and/or dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis may contribute to pathophysiologic processes in panic disorder, but documentation of HPA axis disturbance in panic has been inconsistent. In the current study we examined HPA axis activity in panic disorder over a full circadian cycle, using frequent blood sampling to provide detailed assessment of corticotropin and cortisol secretion.
METHODS: Twenty patients with panic disorder and 12 normal control subjects were studied. Blood samples were drawn every 15 minutes for 24 hours and assayed for corticotropin and cortisol levels.
RESULTS: Patients with panic disorder had elevated overnight cortisol secretion and greater amplitude of ultradian secretory episodes. Patients who entered the study through clinical referral channels had greater cortisol secretion than those recruited by advertisements. Patients with panic disorder who had a low frequency of panic attacks had elevated daytime corticotropin levels and elevated corticotropin ultradian amplitude. Patients with a high frequency of attacks had shifted corticotropin circadian cycles.
CONCLUSIONS: Patients with panic disorder demonstrate subtle alterations in HPA axis activity, characterized by overnight hypercortisolemia and increased activity in ultradian secretory episodes, but HPA axis alterations in panic are modulated by illness severity and treatment seeking. It remains unclear whether HPA axis dysregulation in panic represents a pathogenic defect within the axis itself. Inconsistencies in prior work may reflect the subtlety of the abnormalities seen, differences in clinical characteristics of patients studied, and the use of different probes and measurement contexts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8634010     DOI: 10.1001/archpsyc.1996.01830040059010

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  20 in total

Review 1.  Role of corticotropin releasing factor in anxiety disorders: a translational research perspective.

Authors:  Victoria B Risbrough; Murray B Stein
Journal:  Horm Behav       Date:  2006-07-25       Impact factor: 3.587

Review 2.  Childhood stressful events, HPA axis and anxiety disorders.

Authors:  Carlo Faravelli; Carolina Lo Sauro; Lucia Godini; Lorenzo Lelli; Laura Benni; Francesco Pietrini; Lisa Lazzeretti; Gabriela Alina Talamba; Giulia Fioravanti; Valdo Ricca
Journal:  World J Psychiatry       Date:  2012-02-22

Review 3.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

4.  Heart rate and respiratory response to doxapram in patients with panic disorder.

Authors:  Jose M Martinez; Amir Garakani; Cindy J Aaronson; Jack M Gorman
Journal:  Psychiatry Res       Date:  2015-03-09       Impact factor: 3.222

5.  Management of treatment-resistant panic disorder.

Authors:  Richard L Holt; R Bruce Lydiard
Journal:  Psychiatry (Edgmont)       Date:  2007-10

Review 6.  A meta-analytic review of the association between cortisol reactivity in response to a stressor and attention-deficit hyperactivity disorder.

Authors:  Jaclyn M Kamradt; Allison M Momany; Molly A Nikolas
Journal:  Atten Defic Hyperact Disord       Date:  2017-09-05

Review 7.  Harmful effects of functional hypercortisolism: a working hypothesis.

Authors:  Giacomo Tirabassi; Marco Boscaro; Giorgio Arnaldi
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

8.  Cognitive modulation of endocrine responses to CRH stimulation in healthy subjects.

Authors:  James L Abelson; Samir Khan; Elizabeth A Young; Israel Liberzon
Journal:  Psychoneuroendocrinology       Date:  2009-09-16       Impact factor: 4.905

Review 9.  Innovative approaches for the treatment of depression: targeting the HPA axis.

Authors:  Fiona Thomson; Mark Craighead
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

10.  Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder.

Authors:  Rose C Mantella; Meryl A Butters; Janet A Amico; Sati Mazumdar; Bruce L Rollman; Amy E Begley; Charles F Reynolds; Eric J Lenze
Journal:  Psychoneuroendocrinology       Date:  2008-04-14       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.